Literature DB >> 7498047

Prevalence of viral infections in Mozambican refugees in Swaziland.

E J Van Rensburg1, H R Lemmer, J J Joubert.   

Abstract

The seroprevalence for antibodies to HIV-1, HTLV-1, hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis E virus (HEV) were determined in a large group of Mozambican refugees living in Swaziland. Serum samples were collected from a total of 398 refugees located in the two camps (Ndzevane and Malindza). The prevalence for antibodies in the two camps were as follows: Ndzevane: 1.2% (HIV-1); 2.8% (HTLV-1); 0.3% (HCV); 4% (HEV) and 66% for any HBV marker. Malindza: 10.8% (HIV-1); 5.4% (HTLV-1); nil (HCV); 2% (HEV) and 65.7% for any HBV marker. The difference in the HIV-1 seroprevalence between the two camps was statistically highly significant. The phenomenon is possibly related to the location of the Malindza camp in the northern most populous area of Swaziland, resulting in more frequent contact between refugees and the local Swazi population.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hepatitis; Hiv Infections; Measurement; Migrants; Migration; Mozambique; Population; Population Dynamics; Portuguese Speaking Africa; Prevalence; Refugees; Research Methodology; Research Report; Southern Africa; Swaziland; Viral Diseases

Mesh:

Year:  1995        PMID: 7498047

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  2 in total

1.  A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.

Authors:  R T Perry; C V Plowe; B Koumaré; F Bougoudogo; K L Kotloff; G A Losonsky; S S Wasserman; M M Levine
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

2.  Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy.

Authors:  Choolwe Jacobs; Clarance Chiluba; Cynthia Phiri; Mpala Mwanza Lisulo; Mumba Chomba; Philip C Hill; Samreen Ijaz; Paul Kelly
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.